Resume
Experience
2021-09 - Present
-
Effectively and efficiently allocate statisticians and statistical programmers to projects.
-
Contribute to the Departmental strategy as part of the leadership team to deliver on the vision and mission.
-
Co-ordinate and lead Biostatistics and Data Management activities for projects.
-
Lead functional and cross-functional process improvement initiatives. Two examples are the DEI initiative & Diversity in Clinical Trials.
-
Provide technical leadership and expertise to guide Statisticians when challenges arise in clinical studies and liaise with other business units and/or statistical experts for those situations.
-
Provide expert statistical knowledge and leadership for activities to support the business outside of clinical studies, such as due diligence, complaint/challenge and training.
-
Provide scientific and technical statistical leadership on studies from NCDP through to publication.
-
Interacts with senior internal and external stakeholders on statistical issues.
-
Work as a Study Statistician on more complex projects, including submission projects and as required partake in escalation/troubleshooting activities.
-
Provide Third Party oversight of strategic and tactical partners as related to statistics, statistical programing and data management.
-
Accountable for the successful execution of projects and provide leadership of oversight of Third-Party Vendors.
-
Coaching and mentoring junior staff across BDM.
-
Review/approve protocols, SAPs, CSRs & publications.
-
Provides expert statistical input and leadership in relation to clinical trials, RWD/RWE and other statistical work across multiple categories, including detailed regulatory interactions like a preparations for a recent FDA advisory committee on possible adolescents abuse of NRT sprays.
-
Develop, train, written standards for QTLS and Estimands.
Director of Biostatistics
Haleon
Warren, NJ
2005-11 - 2021-09
Manager, Biostatistics
GSK Consumer Healthcare
Warren, NJ
-
Reviewed and approved protocols, SAPs, CSRs, and publications
-
Developed scalable IVIVC models in lieu of BE studies for manufacturing sites and formulations changes.
-
Lead the QTLs initiative in line with ICH E6 R2 requirements for data integrity and subject safety
-
Lead departmental process improvement initiatives of streamlining and ownership of written standards.
-
Provided statistical leadership on RWD/RWE and MDR PMCF studies.
-
Effectively and timely responded to requests from regulatory agencies and other stakeholders
-
Prepared integrated summaries of safety and efficacy
-
Lead statistician on FDA Advisory Board Meetings
-
Oversaw Junior statisticians by providing mentoring
-
Provided vendor oversight for Statistics deliverables
-
Authored SAPs for analyses done in house
-
A trusted SME on complex Statistics methodologies
-
Developed a vendor selection process.
-
Due diligent vendor qualification assessments.
-
Statistics lead of clinical support for market expansions
-
Internal Statistics consultant on studies & literature
-
Oversee the data disclosure efforts
-
Developed vendor payment models.
2004-05- 2005-11
Senior Statistician
Unilever
Trumbull, CT
-
Enabled the delivery of effective technically defensible, informative, and timely study designs.
-
Leveraged critical thinking in statistical design, sampling, and data analyses
-
Worked on retrospective meta-analysis to gain efficiencies of evaluating Anti-Aging technologies
-
Scouted, identified, and championed novel, value-added data-analytical methodologies.
Education
2003
Ph.D.: Statistics
Kansas State University
Manhattan, KS
2015
MBA
Montclair State University
Montclair, NJ
1998
Master of Science: Mathematics & Statistics
Western Illinois University
Macomb, IL
1996
Bachelor of Science: Mathematics & Statistics
The University of Nairobi Nairobi, Kenya
Professional Skills
Exemplary interpersonal communication skills
Strong team leadership capabilities
Third-party Vendor relations and management
Software
Spotfire
Power BI
nQuery
SAS
PASS
R
GastroPlus
Accomplishments
-
Developed scalable In Vitro In Vivo Correlation models following FDA and EMA regulations in lieu of a clinical BE study that will speed the Transderm Scōp® patch to market with savings
-
Successful integration of GSKCH and Novartis CH integration after a Joint Venture
-
Enabled strategies that improved first time acceptance of study results disclosures to https://clinicaltrials.gov/from 38% to over 80% and 100% second time
Affiliations
-
American Statistical Association
